[Postoperative Cobalt-60-teletherapy and intraperitoneal Gold-198 administration in malignant ovarian tumors].
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000368:Aged; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D003536:Cystadenocarcinoma / Q000532:radiotherapy / Q000601:surgery; D003537:Cystadenoma / Q000532:radiotherapy / Q000601:surgery; D004715:Endometriosis / Q000532:radiotherapy / Q000601:surgery; D005260:Female; D006048:Gold Colloid, Radioactive / Q000627:therapeutic use*; D006106:Granulosa Cell Tumor / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007274:Injections, Intraperitoneal; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage
D003037:Cobalt Radioisotopes; D006048:Gold Colloid, Radioactive
Postoperative Kobalt-60-Teletherapie und intraperitoneale Gold-198-Applikation bei malignen Ovarialtumoren